MA-BRIGHTCOVE
9.2.2021 15:02:10 CET | Business Wire | Press release
Brightcove Inc. (NASDAQ: BCOV), the global leader in video for business, today announced the launch of Brightcove Cloud Playout, a new feature that enhances Brightcove’s end-to-end video platform and makes it one of the few online video providers to offer this capability. Brightcove helps propel businesses forward through video, offering a complete video ecosystem with cutting edge technology, tools, incomparable knowledge, and customer support. The launch of Cloud Playout strengthens Brightcove’s Technology and Engineering Emmy® Award-winning offerings by enabling customers to save even more time and money by consolidating all video needs on a single platform.
Brightcove Cloud Playout is a brand new feature of Brightcove Video Cloud that enables content owners and organizations to quickly and seamlessly program a scheduled playout of both on-demand video assets and live footage or events into a single stream. This provides a broadcast-grade “live TV” experience that leverages pre-recorded content to increase audience engagement and create new revenue opportunities. Customers also benefit from a highly streamlined workflow, as every possible video need is met within Brightcove’s singular all-inclusive platform.
Early adopters of this capability include long-time Brightcove client AMC, as well as global entertainment destination BookMyShow, and more. In March 2021, SXSW Online will be the first Brightcove customer to utilize Cloud Playout for its conference and festivals.
“Horror genre enthusiasts are die-hard fans, and with COVID-19 impacting Halloween celebrations we decided to host ShudderFest, a simulive 24-hour event just for them," said Mike Zagari, EP of ShudderFest. "With Brightcove's Cloud Playout, we were able to quickly pull together our content lineup and save time on our video workflows, as well as reach our global fan base by easily looping the event for every time zone around the world."
"As the ubiquitous platform for all things entertainment, BookMyShow offers several live event formats across music, comedy, theatricals performances and much more with the entire repertoire being available virtually both as both live events and pre-recorded ones such as Sunburn Home Festival, Rambo Circus and international artists including Willie Gomez, The Buckleys, Taylor Castro to name a few hosted on our live entertainment platform BookMyShow Online, powered by Brightcove,” said Parikshit Dar, Co-founder and Director, BookMyShow. "With Brightcove’s newest feature, Cloud Playout, we have been able to be a lot more flexible with our programming, and we finally have an end-to-end platform for our growing video needs."
“Since Brightcove’s inception, video innovation has been a key priority for us, and Cloud Playout demonstrates our commitment to providing our customers with the best technology and tools to help them succeed with video,” said Namita Dhallan, Chief Product Officer of Brightcove. “Cloud Playout is the next innovation in our platform, and by enabling customers to streamline the management and playout of content within a single solution, we’re saving them the additional costs and security risks of utilizing third party apps, while still providing the scalability to reach audiences around the globe, on their schedule.”
With over 50 industry-defining patents, Brightcove lives and breathes video. The company provides its game-changing video capabilities to over 3,300 customers globally. This roster includes industry leaders spanning verticals, from media titans like Showtime Networks and Vox Media, food and beverage giants such as Chick-Fil-A and Dunkin Brands, authorities in entertainment like the Academy of Motion Picture Arts and Sciences, virtual education company MasterClass, sports partners like the USGA, and many more.
About Brightcove
When video is done right, it can have a powerful and lasting effect. Hearts open. Minds change. Creativity thrives. Since 2004, Brightcove has been helping customers discover and experience the incredible power of video through its award-winning technology, empowering organizations in more than 70 countries across the globe to touch audiences in bold and innovative ways.
Brightcove achieves this by developing technologies once thought impossible, providing customer support without parallel or excuses, and leveraging the expertise and resources of a global infrastructure. Video is the world’s most compelling, exciting medium. Visit www.brightcove.com for more information. Video That Means Business.™
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005733/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 20266.7.2026 13:30:00 CEST | Press release
Fully enrolled 123-patient Phase 1b cohort demonstrated 21.2-month median overall survival, 33% three-year overall survival, and a survival curve plateau beyond two yearsData presented in a heavily pretreated population where durable long-term survival is rarely reported17% of patients alive and off all systemic anticancer therapy at last follow-upExtended safety follow-up showed no new safety signals, no treatment-related deaths, and 98% resolution of immune-mediated diarrhea/colitis Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year landmark Phase 1b data from the fully enrolled C-800-01 cohort evaluating botensilimab (BOT), an Fc-enhanced multifunctional anti–CTLA-4 antibody, plus balstilimab (BAL), an anti–PD-1 antibody, in patients with refractory microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) without active liver metastases. The data were presented at the European Society for Medical Oncology Gastrointestinal Cancers (E
LTM Launches BlueVerse™ RightLogic to Address Cyber Risk in AI Era6.7.2026 11:12:00 CEST | Press release
New assessment and risk assurance framework helps enterprises gain unified visibility, prioritise remediation and scale AI securely LTM, the Business Creativity partner to the world’s largest enterprises, has launched BlueVerse™ RightLogic, a cybersecurity assessment and risk assurance framework designed to help enterprises identify, assess and remediate cyber exposure as they accelerate AI adoption. AI is now capable of autonomously identifying and exploiting vulnerabilities, while exposure across infrastructure, applications and supply chains continue to expand. This has elevated cyber risk from a technology concern to a board-level priority, with enterprises struggling to maintain visibility and respond at the speed of emerging threats. BlueVerse RightLogic addresses this gap by providing a unified, business-aligned view of enterprise exposure and enabling a shift from fragmented, point-in-time assessments to continuous, evidence-led risk management. The framework combines an end-to
Media Release: Financial Worries Rise and Match Health Concerns as Cost-of-Living Pressures Mount in 20266.7.2026 10:00:00 CEST | Press release
Globally, people are united in their top personal worries: Financial and health issues rank at the top in 2026, averaging 13 percentage points ahead of other concerns.Financial pressure is prominent across Europe, rising in France, Germany, and U.K., and emerging as a top concern in newly measured markets, Spain and Switzerland.Allianz published these results in “The Allianz 3am Report 2026,” which surveyed 10,000 people across 10 countries worldwide about what keeps them awake at night.Addressing financial concerns requires accessible, targeted financial and risk education. To support this, Allianz has launched the “Allianz School For Life” learning platform. Households around the world are feeling the strain of the rising cost of living, with financial pressure increasingly shaping everyday choices and long-term confidence. Finances and health are now tied as the top global worries, at 48% each, followed by concerns about the future at 35%, according to consumer surveys in 10 countri
HAZAMA ANDO Becomes an Official Partner in Helical Fusion’s Commercial Fusion Initiative and Signs MoU Toward Construction of the Fusion Pilot Plant6.7.2026 08:40:00 CEST | Press release
A long-established Japanese general contractor will contribute construction expertise to advance Fusion Pilot Plant development toward commercially viable fusion power. Helical Fusion Co., Ltd. (“Helical Fusion”), a Japan-based fusion energy startup developing fusion power plants, and HAZAMA ANDO CORPORATION (“HAZAMA ANDO”), a long-established Japanese general contractor, today announced that HAZAMA ANDO has become an Official Partner in the Helix Program, Helical Fusion’s commercial fusion initiative. The two companies have also signed a memorandum of understanding (“MoU”) to collaborate toward the construction of Helix KANATA, Helical Fusion’s Fusion Pilot Plant targeted for the 2030s. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706176052/en/ (L-R) Kazuhiko Kuniya (Representative Director and President, HAZAMA ANDO CORPORATION) and Takaya Taguchi (Co-Founder and CEO, Helical Fusion Co., Ltd.) at a press conference in
Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis6.7.2026 07:15:00 CEST | Press release
Sofinnova Partners co-led the seed investment in 2019 and has supported the company from founding through to exitThe proposed acquisition combines the oncology expertise of Novartis with Myricx Bio’s novel ADC assets and platform having broad potential across multiple solid tumor typesMyricx Bio's first-in-class NMTi payload platform is designed to improve the therapeutic index of ADCs, offering the potential for more effective and better-tolerated treatment options for cancer patientsThe transaction valued at up to $1.5 billion including $1.1 billion cash upfront Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to $1.5 billion including $1.1 billion cash upfront plus potential milestone payments. This marks Sofinnova Partners' seventh exit in three years. Myricx Bio is a UK-headquartered transatlantic biotech company focused on the discove
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom